NCT00253032

Brief Summary

The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 15, 2005

Completed
Last Updated

March 3, 2006

Status Verified

March 1, 2006

First QC Date

November 11, 2005

Last Update Submit

March 2, 2006

Conditions

Chronic Musculoskeletal Pain

Interventions

PRIMADEVICE

Sponsors & Collaborators

Related Publications (1)

  • Sepulveda-Sanchez JM, Gil-Gil M, Alonso-Garcia M, Vaz Salgado MA, Vicente E, Mesia Barroso C, Rodriguez Sanchez A, Duran G, De Las Penas R, Munoz-Langa J, Velasco G, Hernandez-Lain A, Hilario A, Navarro Martin M, Benavides M, Oleaga L, Cantero Montenegro D, Ruano Y, Sanchez-Gomez P, Martin-Soberon MC, Morales-Llombart R, Pachon V, Pineda E. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO). Target Oncol. 2020 Oct;15(5):613-622. doi: 10.1007/s11523-020-00754-6.

    PMID: 33025213DERIVED

Study Design

Study Type
interventional
Phase
phase 3
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 11, 2005

First Posted

November 15, 2005

Last Updated

March 3, 2006

Record last verified: 2006-03